Inotropic support in cardiogenic shock: who leads the battle, milrinone or dobutamine?

Cardiovascular diseases remain the leading cause of death globally, with acute myocardial infarction being one of the most frequent. One of the complications that can occur after a myocardial infarction is cardiogenic shock. At present, the evidence on the use of inotropic agents for the management...

Descripción completa

Detalles Bibliográficos
Autores principales: Lozada Martinez, Ivan David, Bayona-Gamboa, Andrea Juliana, Meza-Fandiño, Duvier Fabián, Paz-Echeverry, Omar Andrés, Ávila-Bonilla, Ángela María, Paz-Echeverry, Mario Javier, Pineda-Trujillo, Frank Jaider, Rodríguez-García, Gina Paola, Covaleda-Vargas, Jaime Enrique, Narvaez-Rojas, Alexis Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577832/
https://www.ncbi.nlm.nih.gov/pubmed/36268289
http://dx.doi.org/10.1016/j.amsu.2022.104763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577832/
https://www.ncbi.nlm.nih.gov/pubmed/36268289
http://dx.doi.org/10.1016/j.amsu.2022.104763

Ejemplares similares